3 Phases of a Roadmap with a sequential Range of Investment Opportunities
Why Invest in MEDgomics?
- We are a leader in a rapidly-growing huge market
- Unique methods & IP with durable competitive advantages
- INITIAL Field-proven services
- Led by a pioneer in genostics/pMED with a trained team
- All investment options are projected to yield revenue within 3-18 months
- Compelling exit: public offering or acquisition < 3 years